Jin buys RDY 44.02: Dr. Reddy's Laboratories Launches therapeutic equivalent generic version of Eli Lilly's Cymbalta
Dr. Reddy's Laboratories (NYSE: RDY) has launched Duloxetine Delayed-Release Capsules USP 20 mg, 30 mg and 60 mg, a therapeutic equivalent generic version of CYMBALTA® (Duloxetine¬ Delayed-Release Capsules) in the US market on June 26, 2014. Dr. Reddy's ... ...
58 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home